glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with arginyl-glycyl-aspartyl-serine in 5 studies
| Studies (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Trials (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Recent Studies (post-2010) (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Studies (arginyl-glycyl-aspartyl-serine) | Trials (arginyl-glycyl-aspartyl-serine) | Recent Studies (post-2010) (arginyl-glycyl-aspartyl-serine) |
|---|---|---|---|---|---|
| 162 | 1 | 20 | 503 | 0 | 79 |
| Protein | Taxonomy | glycyl-arginyl-glycyl-aspartyl-seryl-proline (IC50) | arginyl-glycyl-aspartyl-serine (IC50) |
|---|---|---|---|
| Integrin beta-3 | Homo sapiens (human) | 4.17 | |
| Integrin beta-1 | Homo sapiens (human) | 2.2 | |
| Integrin alpha-IIb | Homo sapiens (human) | 4.17 | |
| Integrin alpha-5 | Homo sapiens (human) | 2.2 | |
| Integrin beta | Oryctolagus cuniculus (rabbit) | 5.1 | |
| Glycoprotein IIb | Oryctolagus cuniculus (rabbit) | 5.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrari, P; Groult, V; Hornebeck, W; Jacob, MP; Robert, L; Tixier, JM | 1 |
| Bahr, BA; Chun, D; Esteban, ET; Ji, ZX; Lynch, G; Staubli, U; Xiao, P | 1 |
| Ito, K; Murai, S; Sugano, N; Tanaka, H | 1 |
| Adams, CS; Mansfield, K; Perlot, RL; Shapiro, IM | 1 |
| Adams, CS; Shapiro, IM | 1 |
1 review(s) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and arginyl-glycyl-aspartyl-serine
| Article | Year |
|---|---|
Mechanisms by which extracellular matrix components induce osteoblast apoptosis.
Topics: Animals; Apoptosis; Calcification, Physiologic; Calcium; Cells, Cultured; Chick Embryo; Dose-Response Relationship, Drug; Extracellular Matrix; Oligopeptides; Osteoblasts; Phosphates | 2003 |
4 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and arginyl-glycyl-aspartyl-serine
| Article | Year |
|---|---|
Mechanisms of interaction between human skin fibroblasts and elastin: differences between elastin fibres and derived peptides.
Topics: Adult; Amino Acid Sequence; Binding Sites; Elastin; Extracellular Matrix; Female; Fibroblasts; Fibronectins; Glycoproteins; Humans; Molecular Sequence Data; Oligopeptides; Platelet Aggregation Inhibitors; Receptors, Cell Surface; Skin; Tropoelastin; Vitronectin | 1991 |
Arg-Gly-Asp-Ser-selective adhesion and the stabilization of long-term potentiation: pharmacological studies and the characterization of a candidate matrix receptor.
Topics: Animals; Cell Adhesion; Electric Stimulation; Electrophysiology; Extracellular Matrix; Hippocampus; In Vitro Techniques; Integrins; Long-Term Potentiation; Male; Oligopeptides; Rats; Rats, Sprague-Dawley; Theta Rhythm | 1997 |
Arg-Gly-Asp(RGD) peptides inhibit Streptococcus mitis to adhere to fibronectin.
Topics: Amino Acid Sequence; Bacterial Adhesion; Binding Sites; Fibrinogen; Fibronectins; Oligopeptides; Platelet Aggregation Inhibitors; Receptors, Immunologic; Streptococcus | 1997 |
Matrix regulation of skeletal cell apoptosis II: role of Arg-Gly-Asp-containing peptides.
Topics: 3T3 Cells; Animals; Apoptosis; Biological Transport, Active; Caspase 3; Caspases; Cells, Cultured; Chick Embryo; Chondrocytes; Enzyme Activation; Extracellular Matrix; Humans; Mice; Mitochondria; Models, Biological; Oligopeptides; Osteoblasts; Rats | 2002 |